Sarepta Therapeutics | SRPT - 市值

金融业

USD

USD 3.18B

现金及等价物

USD 464.45M

USD 109.46M

USD 2.31B

USD 499.16M

USD 1.04B

USD 358.43M

USD -252.2M

1.37K

EPS每股收益

USD 3.16

股本和储备

USD 1.51B

USD 621.34M

债务利息支出

USD 20.84M

USD 8.74M

USD 838.16M

USD 1.59B

USD 330.96M

USD 372.37M

USD 358.43M

普通股股本

USD 105.57M

27.27

USD 343.17M

USD 730.8M

销售和管理费用

USD 54.03M

USD 1B

贸易债权人

USD 70.38M

应收帐款人

USD 547.91M

	市值	更改		日
Acadia Pharmaceuticals	USD 3.57B		221M	2026-05
Agios Pharmaceuticals	USD 2.01B		423M	2026-03
Alnylam Pharmaceuticals	USD 44.15B		8.39B	2026-03
Amgen	USD 189.89B		13.64B	2026-03
BioCryst Pharmaceuticals	USD 1.66B		64M	2025-12
Biogen	USD 26.9B		1.09B	2026-03
BioMarin Pharmaceutical	USD 10.18B		683M	2026-05
Capricor Therapeutics	USD 1.66B		1.33B	2025-12
Daiichi Sankyo	JPY 6.34T		62.51B	2025-12
Eli Lilly	USD 869.02B		146.97B	2026-03
Esperion Therapeutics	USD 885M		351M	2025-12
Gilead Sciences	USD 167.39B		5.6B	2026-05
Incyte	USD 21.73B		3B	2026-05
Insmed	USD 15.56B		19.73B	2026-05
Ionis Pharmaceuticals	USD 12.46B		356M	2026-03
Moderna	USD 20.15B		8.53B	2026-03
Nektar Therapeutics	USD 15.62B		14.76B	2026-05
Neurocrine Biosciences	USD 15.15B		1.9B	2026-05
Novavax	USD 1.09B		316M	2025-12
Pfizer	USD 147.4B		6.42B	2026-05
PTC Therapeutics	USD 4.94B		698M	2026-05
Regeneron Pharmaceuticals	USD 81.68B		560M	2026-03
Roche Holding	CHF 266.34B		55.46B	2025-12
Sanofi	EUR 100.27B		605.48M	2026-03
Sarepta Therapeutics	USD 2.16B		123M	2026-05
Tectonic Therapeutic	USD 390M		96M	2025-12
Ultragenyx Pharmaceutical	USD 2.06B		1000K	2026-05
Vertex Pharmaceuticals	USD 113.58B		1000K	2026-05